**Question:** The anticoagulant of choice in pregnancy is:

A. Heparin
B. Warfarin
C. Aspirin
D. Clopidogrel

**Core Concept:**
In pregnant patients, the choice of anticoagulant depends on the specific indication, bleeding risk, and the potential risks and benefits for both the mother and the fetus. Anticoagulants are essential in preventing thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), which have higher incidence during pregnancy due to hormonal changes and blood stasis.

**Why the Correct Answer is Right:**
The correct choice is **A. Heparin**. Heparin is a short-acting anticoagulant that acts by inhibiting the activation of the clotting cascade, specifically blocking the enzyme factor Xa and thrombin. Heparin is a safe choice for pregnant patients as it does not cross the placenta, meaning it does not affect the fetus directly. Additionally, heparin does not interfere with platelet function, reducing the risk of excessive bleeding.

**Why Each Wrong Option is Incorrect:**

**B. Warfarin (Coumadin):**
Warfarin is a vitamin K antagonist, which interferes with the synthesis of clotting factors II, VII, IX, X, XI, and XII. However, it crosses the placenta, potentially causing fetal malformations and bleeding. This makes it contraindicated during pregnancy.

**C. Aspirin (Salicylic Acid):**
Aspirin acts by inhibiting the enzyme cyclooxygenase (COX), which leads to reduced production of prostaglandins (including prostacyclin) and increased platelet aggregation. Aspirin crosses the placenta, making it a less preferable choice for pregnant patients compared to heparin.

**D. Clopidogrel (Plavix):**
Clopidogrel is a P2Y12 inhibitor, blocking adenosine diphosphate (ADP) binding to platelet P2Y12 receptors, leading to reduced platelet aggregation. Similar to aspirin, clopidogrel crosses the placenta, making it less suitable during pregnancy.

**Clinical Pearls:**
1. The choice of anticoagulant in pregnant patients depends on the indication and the risk-benefit ratio.
2. Heparin is a safer option due to its lack of direct impact on the fetus.
3. Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin and clopidogrel are contraindicated during pregnancy due to the potential for fetal malformations and bleeding complications.